MK-8644 / Merck (MSD) - LARVOL DELTA

A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001) (clinicaltrials.gov) - P1 | N=132 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC

First-in-human • New P1 trial • Dermatology • Immunology • Psoriasis